Nil Albiol

12PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAutoimmunityTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 12, 2026
Infections in Patients With Cytokine Release Syndrome/Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell Therapy.

|Jun 08, 2026
Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphoma.

|Jun 04, 2026
Cesni-cel (ARI0002h) in ultra-high-risk multiple myeloma with plasma cell leukaemia or central nervous system involvement.

|Dec 11, 2025
Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia.

Miguel Arguello-Tomas, Elionor Lynton-Pons, Nil Albiol

|Oct 16, 2025
Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report.

Daniel Munarriz, Oriana López-Godino, Nuria Martinez-Cibrian

|Nov 27, 2024
Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia.

Juan A Piñeyroa, Irene López-Oreja, Ferran Nadeu

Pageof 2

Frequent Collaborators

4 joint publications

Pablo Mozas

3 joint publications

Miguel Arguello-Tomas

3 joint publications

Carlos Fernández de Larrea

2 joint publications

Irene García-Cadenas